NEKTAR THERAPEUTICS — Director's Dealing 2016

Sep 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2016-09-15

Reporting Person: KUEBLER CHRISTOPHER A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-15	Common Stock	M	15000	$0.00	Acquired	35000	Direct
2016-09-16	Common Stock	S	7500	$19.13	Disposed	27500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-15	Restricted Stock Unit	$	M	15000	Disposed		Common Stock (15000)	Direct

Footnotes

F1: Represents restricted stock units ("RSU"), convertible on a one-for-one basis into shares of Common Stock of the Company. These RSUs, at the time of their grant on September 15, 2015, vested in full one year following the grant date.

F2: The total holdings include 15,000 shares of restricted stock units ("RSUs") that were previously reported in Table II for the reporting person and which are being reclassified to Table I. These RSUs were granted on September 15, 2015, are convertible on a one-for-one basis into shares of Common Stock of the Company and vested on September 15, 2016.

F3: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4: This transaction was executed in multiple trades at prices ranging from $18.94 to $19.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.